Cancer prevalence set to treble

August 21, 2012
Cancer prevalence set to treble

(Medical Xpress) -- The number of older people (aged 65 and over) living with cancer in the UK is set to more than treble by 2040 – from 1.3 million in 2010 to 4.1 million – according to a new study by King’s College London researchers.

The Macmillan-funded study, published in The British Journal of , shows nearly one in four (23 per cent) will have had a cancer diagnosis in 2040 – almost double the proportion in 2010 (13 per cent). This is nearly four times the proportion for people aged 45-64.

Lung cancer prevalence in older women will see the biggest increase. The prevalence of lung cancer in older women will more than double from in 2010 to 2040 (from 319 to 831 per 100, 000), whereas lung cancer prevalence in older men is expected to decrease. This is due to a dramatic decline in smoking among men in England since the 1970s.

The sharp rise in cancer prevalence is likely to be due to a number of reasons including the ageing population, increasing incidence and increasing cancer survival.

Professor Henrik Møller, one of the study authors at King’s, says: ‘The aim of this research is to provide long term projections of cancer prevalence in the UK. The research shows that large increases can be expected in the oldest age groups in the coming decades and with this an increased demand upon health services.’

Currently older face a multitude of barriers to getting the best care and . These include under treatment, a lack of practical support at home preventing them from going to hospital to get treatment and poor management of non-cancer related health problems.

Ciarán Devane, Chief Executive at Macmillan Cancer Support, said: ‘The care of older cancer patients is the ticking time bomb for society. These stark predictions should act as a warning to the NHS and social care providers of the problems ahead if older cancer patients are not offered the best treatment and support.

‘We have a moral duty to give people the best chance of beating cancer, regardless of their age. For cancer survival to improve, older people must be given the right treatment at the correct level of intensity, together with the practical support to enable them to take it up.

‘The barriers to older people getting treatment must be tackled. If we don’t get this right now many older people will be dying unnecessarily from cancer in the future.’

Macmillan is calling for a more effective way of assessing older people for treatment, more short-term practical support to enable them to take up recommended treatment and training for professionals working with older people within the NHS to promote age equality.

Macmillan, in partnership with Age UK and the Department of Health, has set up five pilots to test new models of older people’s care. They will report in December 2012.

Explore further: Age affects risk of being diagnosed with cancer at advanced stage

More information: Maddams J, Utley M and Møller H. 2012. 'Projections of cancer prevalence in the United Kingdom, 2010–2040'. British Journal of Cancer. www.nature.com/bjc/journal/vao … ull/bjc2012366a.html

Related Stories

Age affects risk of being diagnosed with cancer at advanced stage

March 2, 2012
Older women with breast cancer face a higher risk of being diagnosed with the disease at a late stage, while the risk of an advanced stage diagnosis of lung cancer decreases with age, a new study shows today.

Elderly breast cancer patients less likely to get surgery

June 17, 2011
(PhysOrg.com) -- University of Manchester researchers, working with colleagues in York, Leeds and Hull, looked at the records of more than 23,000 women with breast cancer diagnosed in the West Midlands, Yorkshire and North ...

Almost half of cancer survivors have ill health in later years

October 11, 2011
Forty-five per cent of cancer survivors in Northern Ireland suffer from physical and mental health problems years after their treatment has finished, according to new research from Macmillan Cancer Support and Queen's University ...

Women, elderly, minorities poorly represented in lung cancer drug trial data submitted to US FDA

July 6, 2011
Women, older people and minorities are enrolled less frequently in lung cancer drug trials and the numbers do not reflect the prevalence of lung cancer in these populations, according to research presented at the 14th World ...

Report estimates nearly 18 million cancer survivors in US by 2022

June 14, 2012
The number of Americans with a history of cancer, currently estimated to be 13.7 million, will grow to almost 18 million by 2022, according to a first-ever report by the American Cancer Society in collaboration with the National ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.